Ball & Co Wealth Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Ball & Co Wealth Management's PBYI Position: Q3 2026 in Review
Ball & Co Wealth Management sold out of Puma Biotechnology (PBYI) in Q3 2026, closing a stake of 3,066 shares — an estimated $24K sold.
Ball & Co Wealth Management first reported a position in PBYI in Q4 2024 and held it in 7 quarters. The position peaked at $24K in Q2 2026. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Ball & Co Wealth Management reported no remaining Puma Biotechnology position as of Q3 2026 after selling out during the quarter.
- Ball & Co Wealth Management sold 3,066 Puma Biotechnology shares in Q3 2026, an estimated $24K.
- Ball & Co Wealth Management first reported a position in Puma Biotechnology in Q4 2024 and held it in 7 quarters.
- Ball & Co Wealth Management's Puma Biotechnology position peaked at $24K in Q2 2026.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Ball & Co Wealth Management's 13F filing for Q3 2026, filed 5 Nov 2026.